Phaseline

Targets › MMP1

MMP1 (Interstitial collagenase): drug programs, companies and trials

19 programs from 19 companies in 22 trials: 10 Phase 2, 9 Phase 4, 2 Phase 1, 1 Phase 3; Infectious disease, Immunology, Cardiovascular; next expected readout Dec 2026.

Cleaves collagens of types I, II, and III at one site in the helical domain. Also cleaves collagens of types VII and X. In case of HIV infection, interacts and cleaves the secreted viral Tat protein, leading to a decrease in neuronal Tat's mediated neurotoxicity. (UniProt, P03956)

Open in Phaseline: the race on MMP1, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Bangrak STIs CenterDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 4Syphilis InfectionMay 2027
University of PennsylvaniaDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 4AcneJul 2027
Chinese University of Hong KongDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 4Sexually Transmitted Diseases, BacterialDec 2027
University of OxfordDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 4Scrub TyphusOct 2028
University of WashingtonDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 4Gonorrhea Male; SyphilisOct 2028
Emory UniversityDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 4Sexually Transmitted Infections (STI)Apr 2029
WestatDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 4GonorrheaJun 2029
Shanghai Jiao Tong University School of MedicineDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 4Helicobacter Pylori Infection–
National University Hospital, SingaporeDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 3Tuberculosis; Tuberculosis, MeningealNov 2027
Makerere UniversityDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 2Tuberculosis, PulmonaryDec 2026
University of IowaDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 2Exudative Macular DegenerationDec 2026
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Doxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 2EczemaJan 2027
Weill Medical College of Cornell UniversityDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 2EmphysemaFeb 2027
University of MiamiDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 2SeromaMay 2027
Lao-Oxford-Mahosot Hospital Wellcome Trust Research UnitDoxycycline Hyclate
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 2Infectious DiseaseDec 2027
Swiss Cancer InstituteDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 2Breast CancerJun 2028
Hawaii Pacific HealthDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 2Kawasaki Disease–
Massachusetts Eye and Ear InfirmaryDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 1Neurofibromatosis Type 2Dec 2026
University of California, DavisDoxycycline
Matrix metalloproteinase 7 inhibitor; Matrix metalloproteinase 8 inhibitor; Matrix metalloproteinase 13 inhibitor
MMP7, MMP8, MMP13, MMP1Phase 1Acne VulgarisJan 2027

Conditions

Scrub Typhus (2) Helicobacter Pylori Infection (1) Sexually Transmitted Infections (STI) (1) Tuberculosis (1) Tuberculosis, Meningeal (1) Gonorrhea Male (1) Syphilis (1) Sexually Transmitted Diseases, Bacterial (1) Neurofibromatosis Type 2 (1) Breast Cancer (1) Seroma (1) Eczema (1)

Modalities

small molecule (19)

Companies

Shanghai Jiao Tong University School of Medicine (1) Emory University (1) National University Hospital, Singapore (1) University of Washington (1) University of Oxford (1) Chinese University of Hong Kong (1) Massachusetts Eye and Ear Infirmary (1) Swiss Cancer Institute (1) University of Miami (1) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) Weill Medical College of Cornell University (1) University of Iowa (1) University of California, Davis (1) Makerere University (1) Westat (1) Bangrak STIs Center (1) Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit (1) University of Pennsylvania (1) Hawaii Pacific Health (1)

Related targets

MMP7 (19) MMP8 (19) MMP13 (19)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.